Possible Synergy Between Electroconvulsive Therapy and Imipramine: A Case Report

Area of Science:

• Psychiatry
• Neuroscience

Background:

• Major depressive disorder (MDD) is a serious mental health condition.
• Electroconvulsive therapy (ECT) is an effective treatment for severe MDD, particularly when it includes psychotic features.
• Tricyclic antidepressants (TCAs) are a class of antidepressant medications.

Observation:

• A 63-year-old woman with a history of severe MDD experienced treatment resistance.
• Her third episode of MDD with psychotic features responded well to ECT.
• Following a relapse, a second ECT course yielded slow response and incomplete remission.
• A subsequent rapid relapse responded effectively to a combination of ECT and imipramine (a TCA).

Findings:

• The combination of ECT and imipramine demonstrated rapid and effective treatment in a patient with severe, recurrent MDD.
• This case suggests a potential synergistic effect between ECT and TCAs in enhancing antidepressant efficacy.
• The combination may be particularly beneficial for patients who do not achieve full remission with ECT alone or experience rapid relapse.

Implications:

• Combining ECT with TCAs could be a valuable strategy for managing complex and treatment-resistant depression.
• Further research is warranted to explore the efficacy and safety of this combined treatment approach.
• This approach may offer improved outcomes for patients with severe MDD who are non-responsive or relapse quickly.